Navigation Links
Mast Therapeutics Reports Fourth Quarter And Full Year 2012 Financial Results
Date:3/19/2013

SAN DIEGO, March 19, 2013 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today reported financial results for the fourth quarter and year ended December 31, 2012.

Brian M. Culley , Chief Executive Officer, said: "2013 will be an exciting year for Mast Therapeutics.  We already have accomplished several key objectives, including initiating a pivotal phase 3 clinical study in sickle cell disease, initiating a thorough QT study of MST-188, identifying multiple new development opportunities with MST-188 and announcing our plans to develop it in complications of arterial disease." 

Key objectives for the remainder of 2013 include:

  • Announcing results from the thorough QT/QTc study of MST-188, expected mid-year;
  • Soliciting FDA input on our planned phase 2 study in acute limb ischemia, expected in the third quarter;
  • Announcing results of nonclinical studies evaluating the physiologic significance of TEG results observed in prior nonclinical studies funded by the Defense Advanced Research Projects Agency (DARPA) Surviving Blood Loss (SBL) program, expected in the second half of the year;
  • Initiating a microvascular blood flow sub-study in EPIC, expected in the fourth quarter;
  • Initiating a phase 2 clinical proof-of-concept study of MST-188 in acute limb ischemia, expected in late 2013/early 2014;
  • Obtaining orphan drug designation for MST-188 for acute limb ischemia;
  • Submitting application(s) to request funding from the U.S. government to conduct a phase 2 clinical proof-of-concept study with MST-188 for resuscitation of shock following major trauma; and
  • Filling patent applications claiming key aspects of our proprietary manufacturing process. 
  • Mr. Culley continued: "Our strategy in arterial disease is to first demonstrate the utility of MST-188 in patients with acute limb ischemia, an ad
    '/>"/>

    SOURCE Mast Therapeutics
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Echo Therapeutics Achieves ISO 13485 Certification
    2. Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
    3. Echo Therapeutics Appoints Robert Doman to Board of Directors
    4. Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect
    5. ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX"
    6. Cell Therapeutics to Present at the ROTH Capital Partners 25th Annual Growth Stock Conference
    7. PTC Therapeutics Closes $60 Million Private Financing
    8. Orexigen Therapeutics to Host Full Year and Fourth Quarter 2012 Financial Results Conference Call and Webcast
    9. Sorrento Therapeutics Signs Exclusive Option to Acquire IGDRASOL
    10. Todays Research on PDL BioPharma, Dendreon, Medivation, ACADIA Pharma, and Cell Therapeutics
    11. Halozyme Therapeutics to Present at the Barclays 2013 Global Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/19/2014)... , Deutschland, October 19, 2014 ... gefragt. Das Problem dabei ist, dass ... mit der Kompetenz zu teilen. Es ... deshalb freuen wir uns umso mehr, dass es ... ihre Gepflogenheiten bei Kühlketten aufzuschreiben - mit einem ...
    (Date:10/17/2014)... THOUSAND OAKS, Calif. , Oct. 17, 2014 /PRNewswire/ ... appointment of R. Sanders Williams , M.D., president ... L. Mahley Distinguished Professor.  "We are ... the Amgen Board," said Robert A. Bradway , ... deep and distinguished experience in academic medicine and his ...
    (Date:10/17/2014)... 2014 ... has announced the addition of the  ... Automated External Defibrillators (AED) Market"  report ... ,The report North American Automated External ... of devices based upon following sub-segments ...
    Breaking Medicine Technology:Vergleichsbericht zu Pharma-Kühlketten und CRT 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 3Micro Market Monitor : North American Automated External Defibrillators (AED) Market 2
    ... Symmetry Medical Inc. (NYSE: SMA ), a leading ... and other medical markets, announced today that it will release ... 3, 2009 before the market opens on Thursday, November 5, ... 8:00 a.m. ET on Thursday, November 5, 2009. , ...
    ... Ikaria Holdings, Inc. today announced that it has been ... by the New Jersey Business & Industry Association (NJBIA), ... Ikaria earned the award based on criteria including ... creation of new jobs. , "We are delighted that ...
    Cached Medicine Technology:Symmetry Medical to Report Third Quarter 2009 Financial Results on November 5, 2009 2Ikaria Receives Award for Excellence by New Jersey Business & Industry Association 2
    (Date:10/20/2014)... It’s hard to imagine what it’s like to live without ... world, it’s a reality. And while new shoes are considered ... walk barefoot on rocky terrain or sewage-lined streets just to ... , Buckner International's Shoes for Orphan Souls ... to encourage support for Air1 and while also providing new ...
    (Date:10/19/2014)... 20, 2014 Hastings and Hastings, a ... of service throughout the greater Phoenix area and across ... with regard to catastrophic automobile accidents. Statistics have indicated ... and throughout Arizona. As such, Hastings and Hastings has ... representation for those who have been injured through no ...
    (Date:10/19/2014)... Texas (PRWEB) October 20, 2014 ... development for Partial Seizure, complete with comparative analysis ... mechanism of action (MoA), route of administration (RoA) ... featured news and press releases. It also reviews ... Partial Seizure and special features on late-stage and ...
    (Date:10/19/2014)... SweetDressy.com, a professional company of women’s ... for long evening dresses . All the company’s ... the current discount is up to 66 percent off. ... in the fashion field. Its dress specialists are striving ... various parts of the world. All the company’s items ...
    (Date:10/19/2014)... that causes inflammation in the spinal joints and ... ancient Egyptian royal families. Now a new study ... journal of the American College of Rheumatology (ACR), ... condition called diffuse idiopathic skeletal hyperostosis (DISH) in ... 20th Dynasties. , Ankylosing spondylitis is a ...
    Breaking Medicine News(10 mins):Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 2Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 2Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 3Health News:Partial Seizure Therapeutic Pipeline Market Review H2 2014 in a New Report Available at RnRMarketResearch.com 4Health News:Promotion For Beautiful Long Evening Dresses Launched By SweetDressy.com 2Health News:Mummy remains refute antiquity of ankylosing spondylitis 2
    ... March 17 CUREXO Technology Corporation, pioneer in ... products for orthopaedic applications, which is focused on ... they received the NSAI (National Standards of Ireland) ... I.S. EN ISO 13485:2003.CUREXO Technology Company has been ...
    ... 17 FRIED LICE: "You don,t have to be such a ... manufacturing company, is set to introduce the latest in delousing technology. ... Disease Control "CDC" website. The guidelines are clear in stating: "to ... of 130 degrees." Lice Safe was able to adapt a ...
    ... finds, , , TUESDAY, March 17 (HealthDay News) -- ... that black male children may have a greater risk ... survey included 8,203 people, from infants to seniors who ... issues with eggs, milk, peanuts and shrimp. The ...
    ... awarded a project to provide interactive, high-quality medical video for 28 ... will be demonstrating the solutions being implemented at WFUBMC at the ... West Building, Chicago, Illinois. Rivulet is in Booth #2428. , ... ...
    ... - New $2.1 Million SBIR Grant Extends NHGRI ... Whole Genome Imaging and Analysis Platform -PHILADELPHIA, March ... nanoscale platforms for biomedical research, molecular diagnostics and ... II grant from the National Human Genome Research ...
    ... Germgard Lighting LLC, a New Jersey-based, early-phase ... revolutionary, ultra-fast, bare-hand sanitation capability. Germgard,s technology will ... by curtailing infections resulting from stays in hospitals.Hospital ... their families, and undermines the financial well-being of ...
    Cached Medicine News:Health News:CUREXO Technology Corporation Receives Quality Certificate 2Health News:Lice Safe Introduces Licen Tool 2Health News:Wake Forest Baptist and Rivulet Connect New Operating Rooms with Interactive Video 2Health News:Wake Forest Baptist and Rivulet Connect New Operating Rooms with Interactive Video 3Health News:BioNanomatrix Awarded Phase II NIH Grant to Support Development of Its Single-Molecule Nanoscale Whole Genome Analyzer 2Health News:Disruptive Hand Sanitation Product to Save Healthcare Industry Billions 2
    ... Para 5X is a whole blood hematology ... 60C+, 80 and 120, and the Coulter ... offers a unique white cell differential, positioning ... algorithms on the systems. The product offers ...
    ... blood assayed hematology control, offers complete assay ... available with the Coulter GENS, STKS, MAXM ... open-vial stability, 105-day closed-vial stability and is ... The 4.0ml pierceable cap vial is compatible ...
    Abiomed introduces its new intra-aortic balloon (IAB); an easy-to-insert, minimally invasive technology designed to enhance blood flow to the heart and other organs for patients with diminished heart...
    Diagnosoft HARP is designed for rapid analysis of tagged cardiac MR images using the HARP technology, which is packaged into an intuitive, easy-to-use graphic user interface....
    Medicine Products: